{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:07:21Z","timestamp":1794017241122,"version":"4.8.0"},"reference-count":89,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2012,8]]},"abstract":"<jats:p>\n            The objective was to analyze the outcome following prenatal exposure to angiotensin-converting enzyme inhibitors (ACE-Is) or angiotensin receptor antagonists (ARBs). For this purpose, a systematic review of published case reports and case series dealing with intrauterine exposure to ACE-Is or to ARBs using Medline as the source of data was performed. The publications retained for analysis included patients who were described individually, revealing, at minimum, the gestational age, substance used, period of medication intake, and the outcome. In total, 72 reports were included; 37 articles (118 well-documented cases) described the prenatal exposure to ACE-Is; and 35 articles (68 cases) described the prenatal exposure to ARBs. Overall, 52% of the newborns exposed to ACE-Is and 13% of the newborns exposed to ARBs did not exhibit any complications (\n            <jats:italic>P<\/jats:italic>\n            &lt;0.0001). Neonatal complications were more frequent following exposure to ARBs and included renal failure, oligohydramnios, death, arterial hypotension, intrauterine growth retardation, respiratory distress syndrome, pulmonary hypoplasia, hypocalvaria, limb defects, persistent patent ductus arteriosus, or cerebral complications. The long-term outcome is described as positive in only 50% of the exposed children. Fetopathy caused by exposure to ACE-Is or ARBs has relevant neonatal and long-term complications. The outcome is poorer following exposure to ARBs. We propose the term \u201cfetal renin-angiotensin system blockade syndrome\u201d to describe the related clinical findings. Thirty years after the first description of ACE-I fetopathy, relevant complications are, at present, regularly described, indicating that the awareness of the deleterious effect of prenatal exposure to drugs inhibiting the renin-angiotensin system should be improved.\n          <\/jats:p>","DOI":"10.1161\/hypertensionaha.112.196352","type":"journal-article","created":{"date-parts":[[2012,7,3]],"date-time":"2012-07-03T04:58:30Z","timestamp":1341291510000},"page":"444-450","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":312,"title":["Pregnancy Outcome Following Exposure to Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Antagonists"],"prefix":"10.1161","volume":"60","author":[{"given":"Marina","family":"Bullo","sequence":"first","affiliation":[{"name":"From the Department of Pediatrics and Division of Pediatric Nephrology, University Hospital (Inselspital), Berne, Switzerland (M.B., S.T., B.S.B., G.D.S.); Division of Pediatrics, Hospitals Bellinzona and Mendrisio, Bellinzona, Switzerland (M.G.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibylle","family":"Tschumi","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics and Division of Pediatric Nephrology, University Hospital (Inselspital), Berne, Switzerland (M.B., S.T., B.S.B., G.D.S.); Division of Pediatrics, Hospitals Bellinzona and Mendrisio, Bellinzona, Switzerland (M.G.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara S.","family":"Bucher","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics and Division of Pediatric Nephrology, University Hospital (Inselspital), Berne, Switzerland (M.B., S.T., B.S.B., G.D.S.); Division of Pediatrics, Hospitals Bellinzona and Mendrisio, Bellinzona, Switzerland (M.G.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario G.","family":"Bianchetti","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics and Division of Pediatric Nephrology, University Hospital (Inselspital), Berne, Switzerland (M.B., S.T., B.S.B., G.D.S.); Division of Pediatrics, Hospitals Bellinzona and Mendrisio, Bellinzona, Switzerland (M.G.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo D.","family":"Simonetti","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics and Division of Pediatric Nephrology, University Hospital (Inselspital), Berne, Switzerland (M.B., S.T., B.S.B., G.D.S.); Division of Pediatrics, Hospitals Bellinzona and Mendrisio, Bellinzona, Switzerland (M.G.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2009.423"},{"key":"e_1_3_2_3_2","first-page":"133","article-title":"Persistent anuria in a neonat\u00eb: a side effect of captopril","volume":"2","author":"Guignard J","year":"1981","unstructured":"Guignard J, Burgener F, C\u00e1lame A. Persistent anuria in a neonat\u00eb: a side effect of captopril. Int J Pediatr Nephrol. 1981;2:133.","journal-title":"Int J Pediatr Nephrol"},{"key":"e_1_3_2_4_2","first-page":"805","article-title":"Fetal abnormality associated with the use of captopril during pregnancy","volume":"60","author":"Duminy PC","year":"1981","unstructured":"Duminy PC, Burger PD. Fetal abnormality associated with the use of captopril during pregnancy. S Afr Med J. 1981;60:805.","journal-title":"S Afr Med J"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2700"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.48.9.776"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-005-1937-2"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-947162"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.20047"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03345344"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1E250"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)90695-0"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1A013"},{"key":"e_1_3_2_14_2","first-page":"59","article-title":"[Pregnancy under captopril]","volume":"39","author":"Caraman PL","year":"1984","unstructured":"Caraman PL, Miton A, Hurault de Ligny B, Kessler M, Boutroy MJ, Schweitzer M, Brocard O, Ragage JP, Netter P. [Pregnancy under captopril]. Therapie. 1984;39:59\u201362.","journal-title":"Therapie"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-007-0618-8"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-994324"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04759-0"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1159\/000183532"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2003.02139.x"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(90)90846-Y"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-006-0070-1"},{"key":"e_1_3_2_22_2","first-page":"897","article-title":"[Pregnancy under converting enzyme inhibitor]","volume":"14","author":"Ducret F","year":"1985","unstructured":"Ducret F, Pointet P, Lauvergeon B, Jacoulet C, Gagnaire J. [Pregnancy under converting enzyme inhibitor]. Presse Med. 1985;14:897.","journal-title":"Presse Med"},{"key":"e_1_3_2_23_2","first-page":"956","article-title":"Low-dose, short-acting, angiotensin-converting enzyme inhibitors as rescue therapy in pregnancy","volume":"96","author":"Easterling TR","year":"2000","unstructured":"Easterling TR, Carr DB, Davis C, Diederichs C, Brateng DA, Schmucker B. Low-dose, short-acting, angiotensin-converting enzyme inhibitors as rescue therapy in pregnancy. Obstet Gynecol. 2000;96:956\u2013961.","journal-title":"Obstet Gynecol"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1136\/fn.88.2.F154"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)91581-2"},{"key":"e_1_3_2_26_2","first-page":"295","article-title":"Olmesartan medoxomil-induced acute renal failure in a premature newborn following maternal exposure during pregnancy: a case report and review of the literature","volume":"2","author":"Georgaki-Angelaki E","year":"2009","unstructured":"Georgaki-Angelaki E, Stergiou N, Naoum E, Papassotiriou I, Anagnostakou M. Olmesartan medoxomil-induced acute renal failure in a premature newborn following maternal exposure during pregnancy: a case report and review of the literature. Nephrol Dial Transplant Plus. 2009;2:295\u2013297.","journal-title":"Nephrol Dial Transplant Plus"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2009.02.004"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfi288"},{"key":"e_1_3_2_29_2","first-page":"624","article-title":"[Transient renal failure in a newborn due to angiotensin receptor II antagonist use during pregnancy: report of a case]","volume":"136","author":"Hasbun HJ","year":"2008","unstructured":"Hasbun HJ, Valdes RE, San Martin OA, Catalan MJ, Salinas QS, Parra CM. [Transient renal failure in a newborn due to angiotensin receptor II antagonist use during pregnancy: report of a case]. Rev Med Chil. 2008;136:624\u2013630.","journal-title":"Rev Med Chil"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04758-9"},{"key":"e_1_3_2_31_2","first-page":"673","article-title":"Angiotensin-converting enzyme inhibitors in pregnancy may result in neonatal renal failure","volume":"78","author":"Hulton SA","year":"1990","unstructured":"Hulton SA, Thomson PD, Cooper PA, Rothberg AD. Angiotensin-converting enzyme inhibitors in pregnancy may result in neonatal renal failure. S Afr Med J. 1990;78:673\u2013676.","journal-title":"S Afr Med J"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.79.3.434"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1447-0756.2008.00762.x"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)90058-5"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1L332"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1988.tb06619.x"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04757-7"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2006.101717"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1159\/000190179"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)64207-9"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1000880"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)05426-5"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)90329-2"},{"key":"e_1_3_2_44_2","first-page":"796","article-title":"Management of severe hypertension in pregnancy by a combined drug regimen including captopril: case report","volume":"96","author":"Millar JA","year":"1983","unstructured":"Millar JA, Wilson PD, Morrison N. Management of severe hypertension in pregnancy by a combined drug regimen including captopril: case report. N Z Med J. 1983;96:796\u2013798.","journal-title":"N Z Med J"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-008-1091-8"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jp.7210766"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2010.01.010"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02730601"},{"key":"e_1_3_2_49_2","first-page":"697","article-title":"[Fetopathy associated with exposure to angiotensin converting enzyme inhibitors]","volume":"23","author":"Neves S","year":"2010","unstructured":"Neves S, Santos R, Gomes C, Correia AJ. [Fetopathy associated with exposure to angiotensin converting enzyme inhibitors]. Acta Med Port. 2010;23:697\u2013700.","journal-title":"Acta Med Port"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0368-2315(06)76471-7"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jp.7210871"},{"key":"e_1_3_2_52_2","first-page":"429","article-title":"Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors","volume":"80","author":"Piper JM","year":"1992","unstructured":"Piper JM, Ray WA, Rosa FW. Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors. Obstet Gynecol. 1992;80:429\u2013432.","journal-title":"Obstet Gynecol"},{"key":"e_1_3_2_53_2","first-page":"2175","article-title":"[Inhibition of angiotensin converting enzyme in human pregnancy. 15 cases]","volume":"14","author":"Plouin PF","year":"1985","unstructured":"Plouin PF, Tchobroutsky C. [Inhibition of angiotensin converting enzyme in human pregnancy. 15 cases]. Presse Med. 1985;14:2175\u20132178.","journal-title":"Presse Med"},{"key":"e_1_3_2_54_2","first-page":"258","article-title":"An unusual case of neonatal anuria","volume":"40","author":"Prasad N","year":"2003","unstructured":"Prasad N, Gulati S, Jain M, Tewari P. An unusual case of neonatal anuria. Indian Pediatr. 2003;40:258\u2013260.","journal-title":"Indian Pediatr"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V391575"},{"key":"e_1_3_2_56_2","first-page":"497","article-title":"[Fetal and neonatal effects of maternal treatment with angiotensin converting enzyme inhibitor]","volume":"1","author":"Rhabbour M","year":"1994","unstructured":"Rhabbour M, Lenoir S, Bouissou F, Rolland M, Fournie A. [Fetal and neonatal effects of maternal treatment with angiotensin converting enzyme inhibitor]. Arch Pediatr. 1994;1:497\u2013500.","journal-title":"Arch Pediatr"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gyobfe.2007.03.015"},{"key":"e_1_3_2_58_2","first-page":"371","article-title":"Neonatal anuria with maternal angiotensin-converting enzyme inhibition","volume":"74","author":"Rosa FW","year":"1989","unstructured":"Rosa FW, Bosco LA, Graham CF, Milstien JB, Dreis M, Creamer J. Neonatal anuria with maternal angiotensin-converting enzyme inhibition. Obstet Gynecol. 1989;74:371\u2013374.","journal-title":"Obstet Gynecol"},{"key":"e_1_3_2_59_2","first-page":"189","article-title":"Can captopril cause fetal and neonatal renal failure?","volume":"4","author":"Rothberg AD","year":"1984","unstructured":"Rothberg AD, Lorenz R. Can captopril cause fetal and neonatal renal failure? Pediatr Pharmacol (New York). 1984;4:189\u2013192.","journal-title":"Pediatr Pharmacol (New York)"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03648-5"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.10081"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-108-2-215"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(89)90197-X"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2004.00525.x"},{"key":"e_1_3_2_65_2","first-page":"1335","article-title":"Prolonged exposure to angiotensin-converting enzyme inhibitors during pregnancy. Fetal toxicity could be reversible","volume":"51","author":"Shrim A","year":"2005","unstructured":"Shrim A, Berger H, Kingdom J, Hamoudi A, Shah PS, Koren G. Prolonged exposure to angiotensin-converting enzyme inhibitors during pregnancy. Fetal toxicity could be reversible. Can Fam Physician. 2005;51:1335\u20131337.","journal-title":"Can Fam Physician"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-006-0162-y"},{"key":"e_1_3_2_67_2","first-page":"306","article-title":"Severe neonatal renal failure after maternal use of angiotensin II type I receptor antagonists","volume":"30","author":"Sinelli MT","year":"2008","unstructured":"Sinelli MT, Cattarelli D, Cortinovis S, Maroccolo D, Chirico G. Severe neonatal renal failure after maternal use of angiotensin II type I receptor antagonists. Pediatr Med Chir. 2008;30:306\u2013308.","journal-title":"Pediatr Med Chir"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1993.tb14242.x"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.1080\/10641950601147937"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1080\/14767050500217244"},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.1080\/j.1600-0412.1998.770517.x"},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-011-2027-2"},{"key":"e_1_3_2_73_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0030-1269895"},{"key":"e_1_3_2_74_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2834.2011.01250.x"},{"key":"e_1_3_2_75_2","first-page":"643","article-title":"[Captopril treatment of severe arterial hypertension in pregnancy]","volume":"16","author":"Hurault de Ligny B","year":"1987","unstructured":"Hurault de Ligny B, Mintz P, Ryckelynck JP, Herlicoviez M, Muller G, Levy G. [Captopril treatment of severe arterial hypertension in pregnancy]. J Gynecol Obstet Biol Reprod (Paris). 1987;16:643\u2013648.","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"e_1_3_2_76_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10194-009-0182-7"},{"key":"e_1_3_2_77_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055202"},{"key":"e_1_3_2_78_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1001490"},{"key":"e_1_3_2_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2007.09.009"},{"key":"e_1_3_2_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2011.02.008"},{"key":"e_1_3_2_81_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e328341885d"},{"key":"e_1_3_2_82_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-010-2040-1"},{"key":"e_1_3_2_83_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d4891"},{"key":"e_1_3_2_84_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006250-200208000-00029"},{"key":"e_1_3_2_85_2","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.20102"},{"key":"e_1_3_2_86_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02254221"},{"key":"e_1_3_2_87_2","doi-asserted-by":"publisher","DOI":"10.2131\/jts.34.SP245"},{"key":"e_1_3_2_88_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(94)90172-4"},{"key":"e_1_3_2_89_2","first-page":"128","article-title":"Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy","volume":"78","author":"Hanssens M","year":"1991","unstructured":"Hanssens M, Keirse MJ, Vankelecom F, Van Assche FA. Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy. Obstet Gynecol. 1991;78:128\u2013135.","journal-title":"Obstet Gynecol"},{"key":"e_1_3_2_90_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(80)91723-7"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.112.196352","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T09:33:16Z","timestamp":1715592796000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.112.196352"}},"subtitle":["A Systematic Review"],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":89,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.112.196352"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.112.196352","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"2012-04-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-06-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-07-02","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}